BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25152517)

  • 1. Loss of PP2A and PTEN immunoexpression coexists with survivin overexpression in adenomyosis.
    Zhang H; Liu J; Zhao X; Liang B; Wen Z; Li M
    Reprod Biol; 2014 Sep; 14(3):200-5. PubMed ID: 25152517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linc-ROR promotes endometrial cell proliferation by activating the PI3K-Akt pathway.
    Xu XY; Zhang J; Qi YH; Kong M; Liu SA; Hu JJ
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2218-2225. PubMed ID: 29762822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch1 receptor regulates AKT protein activation loop (Thr308) dephosphorylation through modulation of the PP2A phosphatase in phosphatase and tensin homolog (PTEN)-null T-cell acute lymphoblastic leukemia cells.
    Hales EC; Orr SM; Larson Gedman A; Taub JW; Matherly LH
    J Biol Chem; 2013 Aug; 288(31):22836-48. PubMed ID: 23788636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of expressions of Dusp6, Sprouty4, and Sef, negative regulators of FGF2/ERK1/2 signaling, in the endometrium of women with adenomyosis.
    Guo Q; Zhang H; Zhao X; Fu Y; Zhang J; Li M
    Int J Gynecol Pathol; 2014 May; 33(3):288-97. PubMed ID: 24681741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL8 enhances proliferation and growth and reduces apoptosis in endometrial stromal cells in an autocrine manner via a CXCR1-triggered PTEN/AKT signal pathway.
    Li MQ; Luo XZ; Meng YH; Mei J; Zhu XY; Jin LP; Li DJ
    Hum Reprod; 2012 Jul; 27(7):2107-16. PubMed ID: 22563025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatoid Arthritis Fibroblast-like Synoviocyte Suppression Mediated by PTEN Involves Survivin Gene Silencing.
    Chen D; Liu D; Liu D; He M; Peng A; Xu J; Lin L; Luo F; Chen L; Huang X; Zhuang J; Xu J
    Sci Rep; 2017 Mar; 7(1):367. PubMed ID: 28337018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1-IRIS overexpression promotes cisplatin resistance in ovarian cancer cells.
    Chock KL; Allison JM; Shimizu Y; ElShamy WM
    Cancer Res; 2010 Nov; 70(21):8782-91. PubMed ID: 20940403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin inhibits growth of eutopic stromal cells from adenomyotic endometrium via AMPK activation and subsequent inhibition of AKT phosphorylation: a possible role in the treatment of adenomyosis.
    Xue J; Zhang H; Liu W; Liu M; Shi M; Wen Z; Li C
    Reproduction; 2013 Oct; 146(4):397-406. PubMed ID: 23904524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of PI3K/Akt/mTOR signaling pathway triggered by PTEN downregulation in the pathogenesis of Crohn's disease.
    Long SH; He Y; Chen MH; Cao K; Chen YJ; Chen BL; Mao R; Zhang SH; Zhu ZH; Zeng ZR; Hu PJ
    J Dig Dis; 2013 Dec; 14(12):662-9. PubMed ID: 23962154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the PTEN tumor gene and risk of endometriosis: a case-control study.
    Govatati S; Kodati VL; Deenadayal M; Chakravarty B; Shivaji S; Bhanoori M
    Hum Reprod; 2014 Feb; 29(2):324-36. PubMed ID: 24154570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursolic acid-induced apoptosis in K562 cells involving upregulation of PTEN gene expression and inactivation of the PI3K/Akt pathway.
    Wu B; Wang X; Chi ZF; Hu R; Zhang R; Yang W; Liu ZG
    Arch Pharm Res; 2012 Mar; 35(3):543-8. PubMed ID: 22477202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant Akt Activation During Implantation Window in Infertile Women With Intramural Uterine Fibroids.
    Makker A; Goel MM; Nigam D; Mahdi AA; Das V; Agarwal A; Pandey A; Gautam A
    Reprod Sci; 2018 Aug; 25(8):1243-1253. PubMed ID: 29113583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrantly expressed long noncoding RNAs in the eutopic endometria of patients with uterine adenomyosis.
    Jiang JF; Sun AJ; Xue W; Deng Y; Wang YF
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():32-7. PubMed ID: 26896594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk between PKCα and PI3K/AKT Signaling Is Tumor Suppressive in the Endometrium.
    Hsu AH; Lum MA; Shim KS; Frederick PJ; Morrison CD; Chen B; Lele SM; Sheinin YM; Daikoku T; Dey SK; Leone G; Black AR; Black JD
    Cell Rep; 2018 Jul; 24(3):655-669. PubMed ID: 30021163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of PTEN expression in psoriatic lesions.
    Li Y; Man X; You L; Xiang Q; Li H; Xu B; Chen Z; Zhang X; Lian S
    Int J Dermatol; 2014 Jul; 53(7):855-60. PubMed ID: 24168180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of PTEN expression does not contribute to PDK-1 activity and PKC activation-loop phosphorylation in Jurkat leukaemic T cells.
    Freeley M; Park J; Yang KJ; Wange RL; Volkov Y; Kelleher D; Long A
    Cell Signal; 2007 Dec; 19(12):2444-57. PubMed ID: 17826953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and significance of bcl-2, bax and ER in foci of adenomyosis].
    Li B; Wang L; Fan Y; Wang J; Guo D
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):923-7. PubMed ID: 23324193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
    Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression.
    Patel R; Gao M; Ahmad I; Fleming J; Singh LB; Rai TS; McKie AB; Seywright M; Barnetson RJ; Edwards J; Sansom OJ; Leung HY
    J Clin Invest; 2013 Mar; 123(3):1157-75. PubMed ID: 23434594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PP2A activity is controlled by methylation and regulates oncoprotein expression in melanoma cells: a mechanism which participates in growth inhibition induced by chloroethylnitrosourea treatment.
    Guénin S; Schwartz L; Morvan D; Steyaert JM; Poignet A; Madelmont JC; Demidem A
    Int J Oncol; 2008 Jan; 32(1):49-57. PubMed ID: 18097542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.